drugset / Trial / NCT00362141

Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus

NCT00362141

Phase 2 Unknown 12 enrolled Medical Center Haaglanden UCB Pharma · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether levetiracetam is safe and well tolerated by patients while suffering a status epilepticus. Levetiracetam is added to the standard treatment of patients with this disease.

Timeline

Start
2006-10
Primary completion
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified Intravenous

Indications